Webinar: Inside the COVID-SeroIndexTM Assay Design and Performance


October 21, 2020 @ 8 am PST / 11 am EST / 4 pm BST
Join our panel of experts as they discuss the rigor involved in optimizing and scaling a reproducible serological assay for COVID-19. Bio-Techne and our partner, Kantaro Biosciences – a Mount Sinai Venture, have developed the COVID-SeroIndexTM, a quantitative ELISA kit that enables an objective measurement of SARS-CoV-2 IgG antibodies which is indicative of a prior COVID-19 infection.  This is a scalable antibody test based on the underlying technology first published by Mount Sinai. In this webinar, we will discuss the assay procedure and performance as well as the assay optimization which provides the user with an accurate and reproducible dataset.


Understanding immune responses to Covid-19 and vaccines to SARS-CoV-2 is essential when profiling disease progression or vaccine efficacy. Bio-Techne and our partner, Kantaro Biosciences – a Mount Sinai Venture, have developed the COVID-SeroIndexTM, a quantitative ELISA kit that enables an objective measurement of SARS-CoV-2 IgG antibodies. Join us as our panel of experts discuss procedure and performance that leads to the fast acquisition of the accurate and proven results required in today’s market.

SPEAKERS


Greta Wegner, Ph.D. Senior Director, ELISAs at Bio-Techne

Greta Wegner, Ph.D.
Senior Director, ELISAs
Bio-Techne


Greta Wegner is the senior director for the ELISA business unit at Bio-Techne in Minneapolis, M. Greta received her Ph.D. in Chemistry at the University of Wisconsin-Madison. In her current role, she leads the product management and development teams designing ELISA, Luminex, and Simple Plex products as well as custom assay solutions.



Mandy Kubik (Luke has headshot and bio)

Mandy Kubik
Manager, Assay Development 
Bio-Techne


Mandy Kubik is a Manager of Assay Development for Bio-Techne. She has more than 20 years of experience in assay and antibody development. Mandy has extensive experience with antibody screening for multiple Bio-Techne assay platforms. She personally developed many monoclonal antibodies and Quantikine ELISAs in Bio-Techne’s portfolio. Currently, Mandy leads the Quantikine ELISA Development team at Bio-Techne.




Mandy Kubik (Luke has headshot and bio)

Anthony Person, Ph.D.
Senior Director, Proteins
Bio-Techne



Anthony Person is the senior director for the Proteins business unit at Bio-Techne in Minneapolis MN. Anthony received his Ph.D. in Cell Biology and Anatomy at the University of Arizona, and has over 10 years of experience developing novel cell-based assays, including those focusing on novel immune checkpoint inhibitors.



Julia Hatler, Ph.D. Senior Director, Antibodies at Bio-Techne

Julia Hatler, Ph.D.
Senior Director, Antibodies
Bio-Techne



Julia Hatler is the senior director for the Antibody business unit at Bio-Techne in Minneapolis MN. Julia received her Ph.D. in Molecular, Cellular, Developmental Biology and Genetics at the University of Minnesota, and has over 10 years of experience in the biotech industry.